Resisting Targeted Therapy: Fifty Ways to Leave Your EGFR

Cancer Cell - United States
doi 10.1016/j.ccr.2011.03.020
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Ways to Transform Your Healing Environment

Nursing & Care Open Access Journal
2017English

Lung Adenocarcinoma: Guiding EGFR-targeted Therapy and Beyond

Modern Pathology
Forensic MedicinePathology
2008English

EGFR Blockade Prevents Glioma Escape From BRAFV600E Targeted Therapy

Oncotarget
Oncology
2015English

EGFR-targeted Cancer Therapy: Promise, Problems and Potential Solutions

Translational Medicine
2011English

‘Imagine More’ Ways to Boost Your Clinical Practice

ASHA Leader
SpeechHearing
2019English

MA27.10 EGFR-Targeted Therapy Alters the Tumor Microenvironment in EGFR-Driven Lung Tumors: Rationale for Combination Therapies

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Looking for Ways to Improve Your Products and Processes?

Chemical and Engineering News
Chemical Engineering
1967English

Targeted Therapy Resistance Mediated by Dynamic Regulation of Extrachromosomal Mutant EGFR DNA

Science
MultidisciplinaryPhilosophy of ScienceHistory
2013English

Trastuzumab Sensitizes Ovarian Cancer Cells to EGFR-targeted Therapeutics

Journal of Ovarian Research
GynecologyOncologyObstetrics
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy